Login:
Tuesday, 8 April 2025
 
The Practitioner 2007;251(1696):19

HPV prevalence underestimated

01 Jul 2007Pais-up subscribers

A study from the USA reinforces the recent recommendation of the US Advisory Committee on Immunization Practices that the new human papillomavirus (HPV) vaccine should be offered to all girls aged 11 and 12.

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

 
 
 
 
 
We use cookies, just to track visits to our website. Accept Cookies What are cookies?